Nifty
Sensex
:
:
17196.70
57696.46
-204.95 (-1.18%)
-764.83 (-1.31%)

Pharmaceuticals & Drugs - API

Rating :
41/99

BSE: 524558 | NSE: NEULANDLAB

1787.60
03-Dec-2021
  • Open
  • High
  • Low
  • Previous Close
  •  1820.20
  •  1838.90
  •  1763.45
  •  1812.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  29544
  •  531.65
  •  2844.40
  •  977.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,293.54
  • 31.75
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,444.31
  • 0.28%
  • 2.88

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 36.22%
  • 5.39%
  • 33.18%
  • FII
  • DII
  • Others
  • 16.01%
  • 0.81%
  • 8.39%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.64
  • 10.11
  • 12.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.11
  • 6.66
  • 20.26

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 41.20
  • 11.47
  • 69.90

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.71
  • 37.63
  • 38.36

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.96
  • 2.87
  • 2.01

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.50
  • 14.55
  • 14.25

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Net Sales
257.85
241.39
6.82%
200.89
205.42
-2.21%
244.71
191.64
27.69%
245.39
203.84
20.38%
Expenses
215.01
200.53
7.22%
175.20
171.58
2.11%
219.19
161.53
35.70%
198.79
175.68
13.15%
EBITDA
42.83
40.86
4.82%
25.69
33.84
-24.08%
25.51
30.12
-15.31%
46.60
28.16
65.48%
EBIDTM
16.61%
16.93%
12.79%
16.47%
10.43%
15.72%
18.99%
13.81%
Other Income
0.29
0.61
-52.46%
2.06
0.70
194.29%
14.60
1.78
720.22%
0.20
1.02
-80.39%
Interest
3.56
3.51
1.42%
3.84
5.37
-28.49%
4.58
7.07
-35.22%
4.44
5.69
-21.97%
Depreciation
11.98
9.27
29.23%
11.83
8.86
33.52%
11.14
7.63
46.00%
10.41
7.82
33.12%
PBT
27.58
28.69
-3.87%
12.07
20.31
-40.57%
24.39
17.20
41.80%
31.95
15.67
103.89%
Tax
7.21
7.25
-0.55%
3.34
5.15
-35.15%
7.10
26.49
-73.20%
5.21
4.56
14.25%
PAT
20.37
21.44
-4.99%
8.73
15.16
-42.41%
17.29
-9.30
-
26.74
11.11
140.68%
PATM
7.90%
8.88%
4.35%
7.38%
7.07%
-4.85%
10.90%
5.45%
EPS
15.79
16.62
-4.99%
6.77
11.75
-42.38%
13.40
-7.21
-
20.72
8.61
140.65%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
948.84
936.91
762.71
666.83
527.41
578.89
509.97
469.15
465.69
460.59
448.50
Net Sales Growth
12.65%
22.84%
14.38%
26.43%
-8.89%
13.51%
8.70%
0.74%
1.11%
2.70%
 
Cost Of Goods Sold
419.43
438.42
380.20
366.24
238.37
262.90
253.46
243.99
246.53
269.20
284.69
Gross Profit
529.41
498.50
382.51
300.59
289.04
315.99
256.52
225.16
219.16
191.39
163.81
GP Margin
55.80%
53.21%
50.15%
45.08%
54.80%
54.59%
50.30%
47.99%
47.06%
41.55%
36.52%
Total Expenditure
808.19
790.09
660.82
608.46
476.98
472.55
429.52
402.53
395.08
402.91
401.69
Power & Fuel Cost
-
39.21
32.75
26.81
25.95
25.78
22.24
22.53
18.31
18.97
15.84
% Of Sales
-
4.19%
4.29%
4.02%
4.92%
4.45%
4.36%
4.80%
3.93%
4.12%
3.53%
Employee Cost
-
149.74
123.56
110.46
102.99
92.74
65.38
51.81
41.74
40.75
35.92
% Of Sales
-
15.98%
16.20%
16.56%
19.53%
16.02%
12.82%
11.04%
8.96%
8.85%
8.01%
Manufacturing Exp.
-
81.08
64.84
50.10
55.54
44.90
39.31
43.56
40.98
35.86
33.76
% Of Sales
-
8.65%
8.50%
7.51%
10.53%
7.76%
7.71%
9.28%
8.80%
7.79%
7.53%
General & Admin Exp.
-
38.93
27.75
27.49
33.32
28.30
29.72
23.59
15.95
16.27
14.27
% Of Sales
-
4.16%
3.64%
4.12%
6.32%
4.89%
5.83%
5.03%
3.43%
3.53%
3.18%
Selling & Distn. Exp.
-
30.65
18.30
18.28
14.04
11.16
17.52
14.54
26.57
13.51
11.42
% Of Sales
-
3.27%
2.40%
2.74%
2.66%
1.93%
3.44%
3.10%
5.71%
2.93%
2.55%
Miscellaneous Exp.
-
12.08
13.42
9.08
6.77
6.78
1.89
2.52
4.99
8.35
11.42
% Of Sales
-
1.29%
1.76%
1.36%
1.28%
1.17%
0.37%
0.54%
1.07%
1.81%
1.29%
EBITDA
140.63
146.82
101.89
58.37
50.43
106.34
80.45
66.62
70.61
57.68
46.81
EBITDA Margin
14.82%
15.67%
13.36%
8.75%
9.56%
18.37%
15.78%
14.20%
15.16%
12.52%
10.44%
Other Income
17.15
16.10
3.89
3.49
4.53
1.17
1.78
0.78
3.44
4.06
2.19
Interest
16.42
17.90
21.57
15.66
18.93
21.09
24.48
27.36
24.56
31.33
33.27
Depreciation
45.36
39.68
31.28
25.86
22.10
19.23
15.74
15.32
14.94
14.62
14.89
PBT
95.99
105.33
52.92
20.34
13.93
67.19
42.00
24.72
34.55
15.78
0.83
Tax
22.86
24.70
36.71
3.90
1.87
20.32
14.92
8.79
7.80
1.96
-1.74
Tax Rate
23.81%
23.45%
69.37%
19.17%
13.42%
30.24%
35.52%
35.56%
22.58%
12.42%
-209.64%
PAT
73.13
80.63
16.21
16.44
12.06
46.86
27.33
15.94
26.80
13.86
2.56
PAT before Minority Interest
73.13
80.63
16.21
16.44
12.06
46.86
27.08
15.93
26.75
13.82
2.57
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.01
0.05
0.04
-0.01
PAT Margin
7.71%
8.61%
2.13%
2.47%
2.29%
8.09%
5.36%
3.40%
5.75%
3.01%
0.57%
PAT Growth
90.39%
397.41%
-1.40%
36.32%
-74.26%
71.46%
71.46%
-40.52%
93.36%
441.41%
 
EPS
57.13
62.99
12.66
12.84
9.42
36.61
21.35
12.45
20.94
10.83
2.00

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
786.46
709.96
699.31
558.04
545.62
186.63
161.38
123.99
99.83
76.12
Share Capital
12.90
12.90
12.90
8.95
8.95
8.95
8.95
7.73
7.72
5.47
Total Reserves
773.56
697.06
686.41
238.24
225.81
177.68
152.42
116.26
92.12
70.63
Non-Current Liabilities
169.82
163.39
104.06
146.43
54.37
69.42
54.76
52.33
61.85
58.90
Secured Loans
88.13
77.37
60.72
103.49
29.81
33.40
21.22
8.87
26.11
55.90
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
12.00
12.00
25.00
25.00
0.00
Long Term Provisions
9.44
12.49
11.91
9.87
9.28
6.85
6.38
5.14
4.71
3.85
Current Liabilities
368.51
357.63
326.98
366.93
285.60
268.00
295.14
306.90
262.99
288.53
Trade Payables
152.13
115.56
119.68
124.29
85.92
83.86
111.81
93.94
82.02
110.85
Other Current Liabilities
158.75
71.63
57.45
41.83
47.18
55.02
31.28
63.74
40.46
40.10
Short Term Borrowings
56.98
168.17
149.06
199.20
151.08
123.63
145.80
139.62
132.68
132.03
Short Term Provisions
0.64
2.27
0.80
1.59
1.41
5.50
6.25
9.61
7.83
5.54
Total Liabilities
1,324.79
1,230.98
1,130.35
1,071.40
885.59
524.05
511.53
483.48
424.98
423.91
Net Block
696.94
622.76
511.69
445.01
435.74
138.77
123.07
130.85
135.52
151.29
Gross Block
826.48
714.33
575.44
483.45
454.74
291.78
263.65
258.54
250.39
254.07
Accumulated Depreciation
129.54
91.57
63.75
38.44
19.00
153.00
140.58
127.69
114.87
102.78
Non Current Assets
775.20
715.79
676.88
624.20
510.54
209.87
195.76
195.93
197.66
201.92
Capital Work in Progress
17.25
23.75
104.47
126.09
19.60
40.48
41.47
34.56
35.69
27.15
Non Current Investment
19.35
30.17
30.21
30.21
30.20
7.39
7.39
7.36
7.36
7.39
Long Term Loans & Adv.
41.67
35.81
30.51
22.66
24.79
22.73
23.83
23.15
10.99
5.50
Other Non Current Assets
0.00
3.30
0.00
0.22
0.22
0.50
0.00
0.00
8.09
10.59
Current Assets
549.59
515.19
453.47
447.19
375.04
314.19
315.77
287.55
227.32
221.98
Current Investments
6.46
7.50
7.50
7.50
7.50
0.00
0.00
0.00
0.00
0.00
Inventories
247.61
219.55
192.65
175.09
135.11
126.66
113.40
93.42
92.17
92.42
Sundry Debtors
217.73
189.89
164.02
193.92
181.11
119.11
128.85
118.59
98.50
96.41
Cash & Bank
19.40
46.98
37.84
17.26
12.49
9.71
6.98
7.07
1.18
2.70
Other Current Assets
58.39
17.47
19.69
16.28
38.83
58.70
66.53
68.47
35.48
30.45
Short Term Loans & Adv.
46.62
33.80
31.77
37.15
25.30
46.68
45.23
43.01
25.66
18.75
Net Current Assets
181.08
157.55
126.49
80.27
89.45
46.18
20.63
-19.35
-35.66
-66.54
Total Assets
1,324.79
1,230.98
1,130.35
1,071.39
885.58
524.06
511.53
483.48
424.98
423.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
189.36
57.34
69.91
11.27
38.68
44.83
13.17
48.77
25.83
49.34
PBT
105.33
52.92
20.34
13.93
67.19
42.00
24.72
34.55
15.78
0.83
Adjustment
40.08
58.28
39.11
40.43
43.96
33.73
36.34
34.37
42.22
44.30
Changes in Working Capital
49.22
-49.17
15.47
-40.02
-55.94
-19.17
-38.76
-16.82
-31.35
4.72
Cash after chg. in Working capital
194.63
62.03
74.91
14.35
55.20
56.56
22.30
52.11
26.65
49.85
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-5.27
-4.68
-5.01
-3.08
-16.52
-11.73
-9.13
-3.34
-0.82
-0.51
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-84.42
-48.68
-77.23
-116.29
-42.11
-19.86
-14.13
-9.84
-7.22
-5.21
Net Fixed Assets
-105.64
-58.17
-70.35
-135.20
-142.08
-27.14
-12.02
-7.02
-4.86
-7.74
Net Investments
11.87
0.04
0.00
-0.01
-30.31
0.12
-0.03
0.00
0.03
0.00
Others
9.35
9.45
-6.88
18.92
130.28
7.16
-2.08
-2.82
-2.39
2.53
Cash from Financing Activity
-113.66
-5.48
11.98
104.85
-0.09
-23.62
1.15
-38.96
-19.90
-43.70
Net Cash Inflow / Outflow
-8.72
3.18
4.66
-0.17
-3.51
1.35
0.19
-0.03
-1.28
0.42
Opening Cash & Equivalents
11.20
7.94
3.29
3.44
6.97
0.81
0.62
0.65
1.93
1.51
Closing Cash & Equivalent
2.44
11.20
7.94
3.29
3.44
2.16
0.81
0.62
0.65
1.93

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
612.28
552.65
544.35
277.21
263.23
209.07
180.72
153.48
123.40
132.65
ROA
6.31%
1.37%
1.49%
1.23%
6.65%
5.23%
3.20%
5.89%
3.26%
0.60%
ROE
10.79%
2.30%
3.48%
5.02%
22.34%
15.64%
11.24%
24.14%
15.92%
3.49%
ROCE
12.81%
7.85%
3.99%
4.07%
15.98%
18.57%
15.75%
18.99%
15.58%
11.35%
Fixed Asset Turnover
1.22
1.18
1.26
1.13
1.57
1.86
1.82
1.87
1.86
1.82
Receivable days
79.40
84.68
97.96
129.34
93.22
87.45
94.81
83.45
75.67
78.78
Inventory Days
91.00
98.63
100.64
106.98
81.29
84.66
79.24
71.34
71.66
69.23
Payable days
62.06
65.43
75.72
82.06
67.03
85.01
92.70
82.14
88.22
97.55
Cash Conversion Cycle
108.34
117.88
122.89
154.27
107.48
87.10
81.35
72.66
59.11
50.45
Total Debt/Equity
0.22
0.37
0.33
1.30
0.82
0.98
1.17
1.55
2.13
2.93
Interest Cover
6.89
3.45
2.30
1.74
4.19
2.72
1.90
2.41
1.50
1.02

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.